Kyntra Bio (KYNB) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 12, 2026, with voting available online or virtually.

• Shareholders are encouraged to review proxy materials and annual report before voting.

Voting matters and shareholder proposals

• Election of Michael Kauffman, M.D., Ph.D. as Class III director until the 2029 annual meeting.

• Advisory vote on executive compensation for named executive officers.

• Ratification of PricewaterhouseCoopers LLP as independent auditor for the year ending December 31, 2026.

• Provision to conduct any other business properly brought before the meeting.

Board of directors and corporate governance

• Board recommends voting in favor of all proposals, including director election and auditor ratification.